CLINICAL_TRIALS
trial_result
· 2024-08-21
Clinical Trial Update: Safety of L1-79 in Adolescent and Adult Males With Autism [Phase 2]
Summary
A Phase 2 trial evaluating the safety of L1-79 in adolescent and adult males with autism has completed, and the results were posted on 2024-08-21.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yamo Pharmaceuticals LLC | Conditions: Autism | Phase 2 | Status: COMPLETED | Results posted: 2024-08-21